Fuller & Thaler Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-6,000
Closed -$123K – 794
2015
Q4
$123K Sell
6,000
-400
-6% -$8.32K ﹤0.01% 452
2015
Q3
$137K Buy
6,400
+2,000
+45% +$44.6K ﹤0.01% 437
2015
Q2
$88K Hold
4,400
– – ﹤0.01% 514
2015
Q1
$69K Buy
+4,400
New +$66.5K ﹤0.01% 558

Other funds holding DXCM

Fuller & Thaler Asset Management's DXCM Position: Q1 2016 in Review

Fuller & Thaler Asset Management sold out of DexCom (DXCM) in Q1 2016, closing a stake of 6,000 shares — an estimated $123K sold.

Fuller & Thaler Asset Management first reported a position in DXCM in Q1 2015 and held it in 4 quarters. The position peaked at $137K in Q3 2015. 264 funds tracked by Wall St. Rank hold DXCM as of Q1 2016.

  • Fuller & Thaler Asset Management reported no remaining DexCom position as of Q1 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 6,000 DexCom shares in Q1 2016, an estimated $123K.
  • Fuller & Thaler Asset Management first reported a position in DexCom in Q1 2015 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's DexCom position peaked at $137K in Q3 2015.
  • 264 funds tracked by Wall St. Rank held DexCom as of Q1 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2016, filed 12 May 2016.